Reference : Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy...
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/262191
Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI)
English
Tuyls, Sebastiaan [Sint Augustinus Ziekenhuis GZA, Antwerpen and UZ Leuven > Pulmonology Department > > >]
Van Der Brempt, Xavier [Clinique Saint-Luc, Bouge > Pulmonology Department and Allergopôle > > >]
Faber, Margaretha [Universitaire Ziekenhuizen Antwerpen and Universiteit Antwerpen > Allergology and Immunology Department, World Allergy Organization (WAO) Center of Excellence > > >]
GADISSEUR, Romy mailto [Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire biochimie automatisée et analyses délocalisées >]
DEZFOULIAN, Bita mailto [Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie >]
Schrijvers, Rik [KU Leuven > Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group > > >]
Froidure, Antoine [Cliniques Universitaires Saint-Luc ; Université Catholique de Louvain > Pulmonology Department, WAO Center of Excellence ; Institut de Recherche Expérimentale et Clinique > > >]
2021
Acta Clinica Belgica
Taylor and Francis
No
International
1784-3286
2295-3337
Abingdon
United Kingdom
[en] COVID-19 ; adverse events ; allergy ; anaphylaxis ; vaccine
[en] Vaccination against COVID-19 constitutes a huge hope and a major challenge. For the first time in modern history, a global vaccination campaign has started worldwide in a short period of time and with products that were recently developed. Consequently, legitimate concerns regarding the safety and tolerability of COVID-19 vaccines arise.In line with international allergy societies, the Belgian Society for Allergy and Clinical Immunology (BelSACI) provides this statement to guide health care providers (general practitioners, specialists including allergists) and stakeholders.In this statement, we first review current evidence on allergic reactions to vaccines and the potential risk factors that have been identified.Second, we provide a risk stratification method that may be used as a worksheet during the vaccination campaign.Finally, we discuss the management of suspected or confirmed allergic reactions following vaccination.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/262191
10.1080/17843286.2021.1909447
https://doi.org/10.1080/17843286.2021.1909447

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Allergic reactions to COVID-19 vaccines- statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).pdfPublisher postprint6.82 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.